Story thread · 2 reports / 2 sources
Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
financialpost.com · 12d
NEW YORK — Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a webcast at 4:30 p.m. EDT on Thursday, August 6, 2026 to report financial results for the second quarter ended […]
First report: Definium Therapeutics (DFTX) Redefines Depression & Anxiety Treatment — finance.yahoo.com, 12d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.